Literature DB >> 27463781

C-reactive protein, platelets, and patent ductus arteriosus.

Leonardo Meinarde1, Macarena Hillman1, Alina Rizzotti1, Ana Lisa Basquiera2, Aldo Tabares3, Eduardo Cuestas1,4.   

Abstract

The association between inflammation, platelets, and patent ductus arteriosus (PDA) has not been studied so far. The purpose of this study was to evaluate whether C-reactive protein (CRP) is related to low platelet count and PDA. This was a retrospective study of 88 infants with a birth weight ≤1500 g and a gestational age ≤30 weeks. Platelet count, CRP, and an echocardiogram were assessed in all infants. The subjects were matched by sex, gestational age, and birth weight. Differences were compared using the χ2, t-test, or Mann-Whitney U-test, as appropriate. Significant variables were entered into a logistic regression model. The association between CRP and platelets was evaluated by correlation and regression analysis. Platelet count (167 000 vs. 213 000 µl-1, p = 0.015) was lower and the CRP (0.45 vs. 0.20 mg/dl, p = 0.002) was higher, and the platelet count correlated inversely with CRP (r = -0.145, p = 0.049) in the infants with vs. without PDA. Only CRP was independently associated with PDA in a logistic regression model (OR 64.1, 95% confidence interval 1.4-2941, p = 0.033).

Entities:  

Keywords:  C-reactive protein; patent ductus arteriosus; platelets

Mesh:

Substances:

Year:  2016        PMID: 27463781     DOI: 10.1080/09537104.2016.1203398

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  6 in total

1.  A promising, novel index in the diagnosis and follow-up of patent ductus arteriosus: Red cell distribution width-to-platelet ratio.

Authors:  Buse Özer Bekmez; Cüneyt Tayman; Mehmet Büyüktiryaki; Aslıhan Köse Çetinkaya; Ufuk Çakır; Turan Derme
Journal:  J Clin Lab Anal       Date:  2018-07-06       Impact factor: 2.352

Review 2.  Paracetamol in Patent Ductus Arteriosus Treatment: Efficacious and Safe?

Authors:  Flaminia Bardanzellu; Paola Neroni; Angelica Dessì; Vassilios Fanos
Journal:  Biomed Res Int       Date:  2017-07-30       Impact factor: 3.411

3.  Platelet Counts and Patent Ductus Arteriosus in Preterm Infants: An Updated Systematic Review and Meta-Analysis.

Authors:  Gema González-Luis; Stefano Ghiradello; Pilar Bas-Suárez; Giacomo Cavallaro; Fabio Mosca; Ronald I Clyman; Eduardo Villamor
Journal:  Front Pediatr       Date:  2021-01-20       Impact factor: 3.418

Review 4.  Current Controversy on Platelets and Patent Ductus Arteriosus Closure in Preterm Infants.

Authors:  Hannes Sallmon; Natalie Timme; Begüm Atasay; Ömer Erdeve; Georg Hansmann; Yogen Singh; Sven C Weber; Elaine L Shelton
Journal:  Front Pediatr       Date:  2021-02-25       Impact factor: 3.418

Review 5.  Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression.

Authors:  Moreyba Borges-Lujan; Gema E Gonzalez-Luis; Tom Roosen; Maurice J Huizing; Eduardo Villamor
Journal:  J Pers Med       Date:  2022-07-14

6.  An Update on Patent Ductus Arteriosus and What is Coming Next.

Authors:  Ömer Erdeve; Emel Okulu; Yogen Singh; Richard Sindelar; Mehmet Yekta Oncel; Gianluca Terrin; Giovanni Boscarino; Ali Bülbül; Hannes Sallmon; Begüm Atasay; Fahri Ovalı; Ronald I Clyman
Journal:  Turk Arch Pediatr       Date:  2022-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.